Common newborn dermatologic conditions

Clinics in Family Practice

Volumn 5, Issue 3, 2003, Pages 535-555

  Stephan, Mark R ^a   Kirby, Mary B ^a   Blackwell, Kelly M ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; BENZOYL PEROXIDE; CLOTRIMAZOLE; CYCLOSPORIN; DIPHENHYDRAMINE; ERYTHROMYCIN; IMMUNOGLOBULIN; ISOTRETINOIN; KETOCONAZOLE; NYSTATIN; PIMECROLIMUS; PLACEBO; RETINOID; SMALLPOX VACCINE; STEROID; TACROLIMUS; TRIMETHOPRIM; VACCINIA VACCINE;

ACNE; ATOPIC DERMATITIS; CAFE AU LAIT SPOT; CLINICAL FEATURE; CLINICAL TRIAL; CONGENITAL NEVUS; DIAPER DERMATITIS; ECZEMA; ERYTHEMA; HEMANGIOMA; HUMAN; LOW LEVEL LASER THERAPY; MELANOSIS; NEVUS; NEVUS FLAMMEUS; NEWBORN; NEWBORN DISEASE; PAPULE; PIGMENT DISORDER; PRURITUS; PSORIASIS; PUSTULE; RASH; REVIEW; SEBORRHEIC DERMATITIS; SKIN APLASIA; SKIN DISEASE; SWEAT GLAND DISEASE; VASCULAR LESION;

EID: 0348038771     PISSN: 15225720     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-5720(03)00066-7     Document Type: Review

References (109)

1. Nanda S, Reddy BSN, Ramji S, Pandhi D. Analytical study of pustular eruptions in neonates. Pediatr Dermatol 2002;19:210-4.
2. Feng E, Janniger CK. Miliaria. Cutis 1995;55:213-6.
3. Mowad CM, McGinley KJ, Foglia A, Leyden JJ. The role of extracellular polysaccharide substance produced by Staphylococcus epidermidis in miliaria. J Am Acad Dermatol 1995;33:729-33.
4. Holzle E, Kligman AM. The pathogenesis of miliaria rubra: role of the resident microflora. Br J Dermatol 1978;99:117-37.
5. Haas N, Henz BM, Wiegel H. Congenital miliaria crystallina. J Am Acad Dermatol 2002;47:S270-2.
6. Straka BF, Cooper PH, Greer KE. Congenital miliaria crystallina. Cutis 1991;47:103-6.
7. Gerritsen MJP, Steijlen PM, Brunner HG, Rieu P. Cutis marmorata telangiectatica congenita: report of 18 cases. Br J Dermatol 2000;142:366-9.
8. Devillers ACA, de Waard-van der Spek FB, Oranje AP. Cutis Marmorata telangiectatica congenita: clinical features in 35 cases. Arch Dermatol 1999;135:34-8.
9. Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol 1986;14:646-60.
10. Pousti TJ, Bartlett RA. Adams-Oliver syndrome: genetics and associated anomalies of cutis aplasia. Plast Reconstr Surg 1997;110:1491-6.
11. Wexler A, Harris M, Lesavoy M. Conservative treatment of cutis aplasia. Plast Reconstr Surg 1990;86:1066-71.
12. Ramamurthy RS, Reveri M, Esterly NB, Fretzin DF, Pildes RS. Transient neonatal pustular melanosis. J Pediatr 1976;88:831-5.
13. Merlob P, Metzker A, Reisner SH. Transient neonatal pustular melanosis. Am J Dis Child 1982;136:521-2.
14. Auster B. Transient neonatal pustular melanosis. Cutis 1978;22:327-8.
15. Wyre HW, Murphy MA. Transient neonatal pustular melanosis. Arch Dermatol 1979;115:458.
16. Janniger CK. Infantile seborrheic dermatitis: an approach to cradle cap. Cutis 1993; 51:233-5.
17. Allen HB, Honig PJ. Scaling scalp diseases in children. Clin Ped 1983;22:374-7.
18. Glover MT, Atherton DJ, Levinsky RJ. Syndrome of erythroderma, failure to thrive, and diarrhea in infancy: a manifestation of immunodeficiency. Pediatr 1988;81:66-72.
19. Stein SL, Paller AS, Haut PR, Mancini AJ. Langerhans cell histiocytosis presenting in the neonatal period. Arch Pediatr Adolesc Med 2001;155:778-83.
20. Tollesson A, Frithz A, Berg A, Karlman G. Essential fatty acids in infantile seborrheic dermatitis. J Am Acad Dermatol 1993;28:957-61.
21. Faergemann J, Bergbrant IM, Dohse M, Scott A, Westgate G. Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry. Br J Dermatol 2001;144:549-56.
22. Kieffer M, Bergbrant IM, Faergemann J, Jemec GBE, Ottevanger V, Skov PS, et al. Immune reactions to Pitosporum ovale in adult patients with atopic and seborrheic dermatitis. J Am Acad Dermatol 1990;22:739-42.
23. Lowe NJ, Breeding JH, Wortzman MS. New coal tar extract and coal tar shampoos. Arch Dermatol 1982;118:487-9.
24. Velen NK, Pilgaard CE, Gade M. Seborrhoeic dermatitis of the scalp treated with a tar/zinc pyrithione shampoo. Clin Exp Dermatol 1980;5:53-6.
25. Peter RU, Richarz-Barthauer U. Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial. Br J Dermatol 1995;132:441-5.
26. Danby FW, Maddin WS, Margesson LJ, Rosenthal D. A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff. J Am Acad Dermatol 1993;29:1008-12.
27. Katsambas A, Antoniou C, Frangouli E, Avgerinou G, Michailidis D, Stratigos J. A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream. Br J Dermatol 1989;121:353-7.
28. Larson FS, Diepgen T, Svenssen A. The occurrence of atopic dermatitis in North Europe: an international questionnaire study. J Am Acad Dermatol 1996;34:760-4.
29. Uehara M. Descendant family history of atopic dermatitis. Acta Derm Venereol 1993;73:62-3.
30. Odom RB, James WD, Berger TG, editors. Atopic dermatitis. In: Andrews' diseases of the skin. 9th edition. Philadelphia: WB Saunders; 2000. p. 69-76.
31. Williams HC, Burney PG, Pembroke AC, Hay RJ. The UK Working Party's Diagnostic Criteria for Atopic Dermatitis III. Independent hospital validation. Br J Dermatol 1994;131:406-16.
32. Eigenmann PA. Prevalence of IgE-mediated food allergy among children with atopic dermatitis. Pediatrics 1998;101:E8.
33. Sampson HA. Food allergy. Part 1: immunopathogenesis and clinical disorders. J Allergy Clin Immunol 1999;103:717-28.
34. Lever R. The role of food in atopic eczema. J Am Acad Dermatol 2001;45:S57-60.
35. Burks AW, James JM, Hiegel A, Wilson G, Wheeler JG, Jones SM, et al. Atopic dermatitis and food hypersensitivity reactions. J Pediatr 1998;132:132-6.
36. Sampson HA. Food allergy. Part 2: diagnosis and management. J Allergy Clin Immunol 1999;103:981-9.
37. Gdalevich M, Mimouni D, David M, Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systemic review and meta-analysis of prospective studies. J Am Acad Dermatol 2001;45:520-7.
38. Cono J, Casey CG, Bell DM. Smallpox vaccination and adverse reactions. MMWR 2003;52:1-28.
39. Jansen T, Burgdorf WHC, Plewig G. Pathogenesis and treatment of acne in childhood. Pediatr Dermatol 1997;14:17-21.
40. Mengesha YM, Hansen RC. Todder-age nodulocystic acne. J Pediatr 1999;134:644-8.
41. Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997;130:30-9.
42. Chew EW, Bingham A, Burrows D. Incidence of acne vulgaris in patients with infantile acne. Clin Exp Dermatol 1990;15:376-7.
43. Tabata N, Terui T, Watanabe M, Tagami H. Infantile acne associated with a high plasma testosterone level in a 21-month-old boy. J Am Acad Dermatol 1995;333:676-8.
44. De Raeve L, De Schepper J, Smitz J. Prepubertal acne: a cutaneous marker of androgen excess? J Am Acad Dermatol 1995;32:181-4.
45. Cunliffe WJ, Baron SE, Coulson H. A clinical and therapeutic study of 29 patients with infantile acne. Br J Dermatol 2001;145:463-6.
46. Arbegast KD, Braddock SW, Lamberty LF, Sawka AR. Treatment of infantile cystic acne with oral isotretinoin: a case report. Pediatr Dermatol 1991;8:166-8.
47. Hurwitz S. Clinical pediatric dermatology. 1st ed. Philadelphia: W.B. Saunders; 1981. p. 27-30.
48. Kazaks EL, Lane AT. Diaper dermatitis. Pediatr Clin North Am 2000;47:909-19.
49. Hoppe JE. Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J 1997;16:885-94.
50. Kozin PJ, Taschdjian CL, Dragutsky D, Minsky A. Cutaneous candidiasis in early infancy and childhood. Pediatrics 1957;20:827-34.
51. Brilliant LC. Perianal streptococcal dermatitis. Am Fam Physician 2000;61:391-3, 397.
52. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20.
53. Takahashi K, Mulliken JB, Kozakewich HPW, Rogers RA, Folkman J, Ezekowitz RAB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994;93:2357-64.
54. Francine B, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998;134: 718-22.
55. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-22.
56. Drolet BA, Esterly NB, Frieden IJ. Primary care: hemangiomas in children. N Engl J Med 1999;341:173-81.
57. Amir. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986;3:331-2.
58. Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001;27:475-85.
59. Frieden IJ, Eichenfield LF, Esterly NB, Geronemus R, Mallory SB. Guidelines of care for hemangiomas in infancy. J Am Acad Dermatol 1997;37:631-7.
60. Garzon MC, Frieden IJ. Hemangiomas: when to worry. Pediatr Ann 2000;29:58-67.
61. Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACES syndrome. J Pediatr 2001;139:117-23.
62. Albright AL, Gartner JC, Wiener ES. Lumbar cutaneous hemangiomas as indicators of tethered spinal cords. Pediatrics 1989;83:977-80.
63. Goldberg NS, Hebert AA, Esterly NB. Sacral hemangiomas and multiple congenital abnormalities. Arch Dermatol 1986;122:684-6.
64. Kasabach HH, Merritt KK. Capillary hemangioma with extensive purpura: report of a case. Am J Dis Child 1940;59:1063-70.
65. Holden KR, Alexander F. Diffuse neonatal hemangiomatosis. Pediatrics 1970;46: 411-21.
66. Orlow SJ, Isakoff MS, Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in the beard distribution. J Pediatr 1997;131:643-6.
67. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 1996;26:3-39.
68. Tanner JL, Dechert BA, Frieden IJ. Growing up with a facial hemangioma: parent and child coping and adaptation. Pediatrics 1998;101:446-52.
69. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990;85:491-8.
70. Gangopadhyay AN, Sinha CK, Gopal SC, Gupta DK, Sahoo SP, Ahmad M. Role of steroid in childhood haemangioma: a ten year review. Int Surg 1997;82:49-51.
71. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992;326:1456-63.
72. Richards KA, Garden JM. The pulsed dye laser for cutaneous vascular and nonvascular lesions. Semin Cutan Med Surg 2000;19:276-86.
73. Kim HJ, Colombo M, Frieden IJ. Ulcerated hemagniomas: clinical characteristics and response to therapy. J Am Acad Dermatol 2001;44:962-72.
74. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982;69:412-20.
75. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-22.
76. Smoller BP, Rosen S. Port-wine stains: a decrease of altered neural modulation of blood vessels? Arch Dermatol 1986;122:177-9.
77. Klapman MH, Yao JF. Thickening and nodules in port-wine stains. J Am Acad Dermatol 2001;44:300-2.
78. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations and associated syndromes. Curr Probl Pediatr 1996;26:3-39.
79. Dohil MA, Baugh WP, Eichenfield LF. Vascular and pigmented birthmarks. Pediatr Clin North Am 2000;47:783-812.
80. Drolet B. Birthmarks to worry about. Pediatr Dermatol 1998;16:447-53.
81. Meine JG, Schwartz RA, Janniger CK. Klippel-Trenaunay-Weber syndrome. Cutis 1997;60:127-32.
82. Leung AKC, Telmesani AMA. Salmon patches in Caucasian children. Pediatr Dermatol 1989;6:185-7.
83. Smith MA, Manfield PA. The natural history of salmon patches in the first year of life. Br J Dermatol 1962;73:31-3.
84. Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4641 newborns. Pediatr Dermatol 1983;1:58-66.
85. Tan KL. Nevus flammeus of the nape, glabella and eyelids. Clin Pediatr 1972;11:112-8.
86. Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976;58:218-22.
87. Esterly NB. Cutaneous hemangiomas, vascular stains, and malformations and associated syndromes. Curr Probl Pediatr 1996;26:3-39.
88. Marghoob AA. Congenital melanocytic nevi: evaluation and management. Dermatol Clin 2002;20:607-16.
89. Swerdlow AJ, English JS, Qiao Z. The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 1995;32:595-9.
90. Illig L, Weidner F, Hundeiker M, Gartmann H, Biess B, Leyh F, et al. Congenital nevi less than or equal to 10 cm as precursors to melanoma: 52 cases, a review, and a new conception. Arch Dermatol 1985;121:1274-81.
91. Kanzler MH, Mraz-Gernhard S. Primary cutaneous melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol 2001;45:260-76.
92. Sahin S, Levin L, Kopf AW, Rao BK, Triola M, Koenig K, et al. Risk of melanoma in medium-sized congenital melanocytic nevi: a follow-up study. J Am Acad Dermatol 1998;39:428-33.
93. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, et al. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997;36:409-16.
94. Egan CL, Oliveria SA, Elenitsas R, Hanson J, Halpern AC. Cutaneous melanoma risk and phenotypic changes in large congenital nevi: a follow-up study of 46 patients. J Am Acad Dermatol 1998;39:923-32.
95. Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4641 newborns. Pediatr Dermatol 1983;1:58-68.
96. Landau M, Krafchik BR. The diagnostic value of café au lait macules. J Am Acad Dermatol 1999;40:877-90.
97. Tekin M, Bodurtha JN, Riccardi VM. Café au lait spots: the physician's perspective. Pediatr Rev 2001;22:82-9.
98. Alper J, Holmes LB, Mihm MC. Birthmarks with serious medical significance: nevo-cellular nevi, sebaceous nevi, and multiple café au lait spots. J Pediatr 1979;95:696-700.
99. Burwell RG, James NJ, Johnston DI. Café au lait spots in schoolchildren. Arch Dis Child 1982;57:631-2.
100. Rivers JK, Kelly JW, Tate BJ, McCarthy WH. The Eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi and other pigmented lesions. J Am Acad Dermatol 1995;32:957-63.
101. McLean DI, Gallagher RP. Sunburn freckles, café-au-lait macules, and other pigmented lesions of schoolchildren: the Vancouver Mole Study. J Am Acad Dermatol 1995;32:565-70.
102. Whitehouse D. Diagnostic value of the café-au-lait spot in children. Arch Dis Child 1966;41:316-9.
103. McCune DJ. Osteitis fibrosa cystica: the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936;52:743-4.
104. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminate, areas of hyperpigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N Engl J Med 1937;216:727-46.
105. Arnsmeier SL, Riccardi VM, Paller AS. Familial multiple café au lait spots. Arch Dermatol 1994;130:1425-6.
106. Abeliovich D, Gelman-Kohan Z, Silverstein S, Lerer I, Chemke J, Merin S, et al. Familial café au lait spots: a variant of neurofibromatosis type 1. J Med Genet 1995;32:985-6.
107. Ricardi VM. Neurofibromatosis and Albright's syndrome. Dermatol Clin 1987;5:193-203.
108. Grossman MC, Anderson RR, Farinelli W, Flotte TJ, Grevelink JM. Treatment of café au lait macules with lasers. Arch Dermatol 1995;131:1416-20.
109. Hoppe JE. Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension.. Pediatr Infect Dis J 1997;16:288-93.